Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects (Q37959379)

25 August 2017

Role of TGF-β in chronic kidney disease: an integration of tubular, glomerular and vascular effects (English)

1 reference

chronic renal insufficiency

25 August 2017

1 reference

based on heuristic

inferred from title

author name string

Francisco J López-Hernández

series ordinal

1

1 reference

PubMed ID

22105921

25 August 2017

Jose M López-Novoa

series ordinal

2

1 reference

25 August 2017

22 November 2011

1 reference

25 August 2017

Cell and Tissue Research

1 reference

25 August 2017

347

1 reference

25 August 2017

1

1 reference

25 August 2017

141-154

1 reference

https://scigraph.springernature.com/pub.10.1007/s00441-011-1275-6

25 August 2017

0 references

cites work

Cellular basis of diabetic nephropathy: V. Endoglin expression levels and diabetic nephropathy risk in patients with Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Angiotensin II induces apoptosis in renal proximal tubular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

TGF-beta in kidney fibrosis: a target for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

TGF-beta in renal injury and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Gap junctional communication in tissue inflammation and repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Role of growth factors in diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Pathogenesis of glomerular damage in glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

TGFβ enforces activation of eukaryotic elongation factor-2 (eEF2) via inactivation of eEF2 kinase by p90 ribosomal S6 kinase (p90Rsk) to induce mesangial cell hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Angiotensin II induces apoptosis in rat glomerular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Molecular basis of renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

The glomerulus--a view from the inside--the endothelial cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

An integrative view on the role of TGF-beta in the progressive tubular deletion associated with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Transforming growth factor beta-induced endothelial-to-mesenchymal transition: a switch to cardiac fibrosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Fibroblast activation and myofibroblast generation in obstructive nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Deletion of H-Ras decreases renal fibrosis and myofibroblast activation following ureteral obstruction in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Role of inflammation in túbulo-interstitial damage associated to obstructive nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Functional symbiosis between endothelium and epithelial cells in glomeruli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Fibrogenesis of parenchymal organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

TGF-beta and glomerulonephritis: anti-inflammatory versus prosclerotic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

TGF-beta receptor function in the endothelium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Regulation of immune responses by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Blockade of endothelial-mesenchymal transition by a Smad3 inhibitor delays the early development of streptozotocin-induced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

The physiological role of endoglin in the cardiovascular system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Inflammation and EMT: an alliance towards organ fibrosis and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Common pathophysiological mechanisms of chronic kidney disease: therapeutic perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Etiopathology of chronic tubular, glomerular and renovascular nephropathies: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Involvement of small Ras GTPases and their effectors in chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

The transforming growth factor-beta family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Tubulointerstitial changes as a major determinant in the progression of renal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Glomerular permeability: a never-ending saga.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Alterations in the expression of the alpha 3 beta 1 integrin in certain membrane domains of the glomerular epithelial cells (podocytes) in diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

TGF-beta: regulation of extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

TGF-beta1 induces COX-2 expression and PGE2 synthesis through MAPK and PI3K pathways in human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Up-regulation of endoglin, a TGF-beta-binding protein, in rats with experimental renal fibrosis induced by renal mass reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Activation of Erk1/2 and Akt following unilateral ureteral obstruction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Angiotensin II: a key factor in the inflammatory and fibrotic response in kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Targeted disruption of TGF-β1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Apoptosis in podocytes induced by TGF-beta and Smad7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

The mesangial cell revisited: no cell is an island

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

TGF-beta signal transduction in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Mesangial cells initiate compensatory tubular cell hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

New insights into mechanisms of fibrosis in immune renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Role of TGF-beta in the progression of renal fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

The TGF-beta paradox in human cancer: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

ERK5 activation enhances mesangial cell viability and collagen matrix accumulation in rat progressive glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

The pathogenesis of progressive renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Transforming growth factor type beta induces monocyte chemotaxis and growth factor production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

CTGF mediates TGF-beta-induced fibronectin matrix deposition by upregulating active alpha5beta1 integrin in human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

TGF-beta and epithelial-to-mesenchymal transitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Different roles for TGF-beta and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-011-1275-6

10.1007/S00441-011-1275-6

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

22105921